Lexaria Bioscience Corp’s proprietary drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier delivery methods and increasing the effectiveness of fat-soluble active molecules and drugs.
The company’s technology can be applied to many different drugs and other active ingredients in oral formats including tablets, capsules, oral suspensions and more.